Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks. Tyndall A, Uccelli A. Source Department of Rheumatology, University of Basel, University Rheumatology Clinic, Basel, Switzerland. alan.tyndall@fps-basel.ch Abstract MSCs, otherwise known as multipotent mesenchymal stromal cells, are being examined for the treatment of autoimmune disease (AD) on the basis of their in vitro…

J Hepatol. 2003 Nov;39(5):679-85. Hemopoietic progenitor cells and bone marrow stromal cells in patients with autoimmune hepatitis type 1 and primary biliary cirrhosis. Kyriakou DS, Alexandrakis MG, Zachou K, Passam F, Stathakis NE, Dalekos GN. Source Hematology Department, University Hospital of Larisa, University of Thessaly, PO BOX 1425, Larisa, Greece. Abstract BACKGROUND/AIMS: Autologous hematopoietic stem…

Expert Rev Gastroenterol Hepatol. 2009 Jun;3(3):269-91. Current and future treatments of autoimmune hepatitis. Czaja AJ. Source Mayo Clinic College of Medicine, Rochester, MN 55905, USA. czaja.albert@mayo.edu Abstract Corticosteroid therapy induces clinical, laboratory and histological improvements in 80% of patients with autoimmune hepatitis. Prednisone, alone or at a lower dose in combination with azathioprine, increases the…